It's an interesting bio.
The nearest competitor, NA1 (NoNo) is currently on Phase 3 trial (expected to completed December 2020).
But AGN's is still pre-clinical.
It takes NoNo 8 years from Phase 1 to Phase 3.
I think it's a long way to go.
ARGENICA THERAPEUTICS LIMITED IPO Analysis, page-2
-
- There are more pages in this discussion • 89 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
88.5¢ |
Change
-0.045(4.84%) |
Mkt cap ! $109.4M | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.0¢ | 88.5¢ | $241.8K | 267.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 43994 | 88.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 90.0¢ | 25400 | 3 |
View Market Depth
| Last trade - 12.23pm 12/07/2024 (20 minute delay) ? |
| AGN (ASX) Chart |